Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents.
about
Psychiatric comorbidities and schizophreniaAsenapine versus placebo for schizophreniaAsenapine versus placebo for schizophreniaAtypical antipsychotics for people with both schizophrenia and depressionAtypical antipsychotics for people with both schizophrenia and depressionUnmet needs in the management of schizophreniaThe substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophreniaPharmacotherapy of schizophrenic patients: preponderance of off-label drug useWorld Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: long-term treatment of schizophrenia.Fluoxetine and olanzapine combination therapy in treatment-resistant major depression: review of efficacy and safety data.A Pilot Study for Discovering Candidate Genes of Chromosome 18q21 in Methamphetamine Abusers: Case-control Association Study.Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trialAre antipsychotics or antidepressants needed for psychotic depression? A systematic review and meta-analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment.Research Domain Criteria: cognitive systems, neural circuits, and dimensions of behavior.Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.Review of functional magnetic resonance imaging studies comparing bipolar disorder and schizophrenia.Treating bipolar disorder. Evidence-based guidelines for family medicine.Elderly patients with schizophrenia and depression: diagnosis and treatmentDifferential diagnosis of depressed mood in patients with schizophrenia: a diagnostic algorithm based on a review.The relationships between depression and remission in first-episode psychosisMeasurement of functional capacity: a new approach to understanding functional differences and real-world behavioral adaptation in those with mental illnessSchizophrenia: a systemic disorderSchizophrenia in the internalizing-externalizing framework: a third dimension?Lurasidone for the treatment of depressive symptoms in schizophrenia: analysis of 4 pooled, 6-week, placebo-controlled studies.Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders.Confirmatory Factor Analysis and Differential Relationships of the Two Subdomains of Negative Symptoms in Chronically Ill Psychotic Patients.Schizophrenia and the eye.Suicidal behavior in schizophrenia.Evaluation of Myo-Inositol as a Potential Biomarker for Depression in SchizophreniaShould bipolar disorder be viewed as manic disorder? Implications for bipolar depression.Mood disorder with psychotic features, schizoaffective disorder, and schizophrenia with mood features: trouble at the borders.Occurrence and treatment of depressive comorbidity/cosyndromality in schizophrenic psychoses: conceptual and treatment issues.Antipsychotic Prescribing Patterns in First-episode Schizophrenia: A Five-year ComparisonAtypical antipsychotics in the treatment of depressive and psychotic symptoms in patients with chronic schizophrenia: a naturalistic studyClozapine and co-prescribed psychotropics: a short report.Study of Relationship Between Depression and Quality of Life in Patients With Chronic Schizophrenia.Personality trait correlates of color preference in schizophreniaDepression in schizophrenia: methodological artifact or distinct feature of the illness?The complement system in schizophrenia.
P2860
Q22242829-6335FD1C-A186-4E20-9F40-CE705D3520E4Q24187012-747CCD36-1A29-43D8-99AA-0FD8F2574819Q24187667-9D53AC22-1C8C-4955-9794-75259A708F40Q24242037-EB989CDD-D60A-4BB2-ABAB-C58DAA824DDEQ24246834-649EDFA1-A09A-4FEB-AA90-B3EF0A075589Q26822917-2FFA495E-7685-4405-B590-B3A1B9644EDAQ28210979-05E43639-FFF1-4654-AB86-468FF8E9153BQ28473574-F8CF12EC-F7C7-475A-B32D-26471EC29D19Q33223628-F59DD388-7393-4336-9FD2-E8EE0D241CA8Q33235110-B24C1293-B74B-4233-8A15-2355903FF879Q33488312-F9FA0617-EDBC-4652-8924-8FAD508191DDQ33618952-BDCD1611-753C-4B39-B9D7-07BF806EF99CQ34007868-4B9683A8-EE27-4859-A75D-4F47D230D274Q34266656-641641F1-DF8D-4912-9B6E-CE0EB2D2EB2EQ34274185-CE5BD76B-47A2-4DDF-9385-E5236D05691BQ34274859-435E4436-EBFC-4FFA-80AB-253B2406A6D6Q34282771-EB3829B8-E1A5-4050-83BF-903DD5156FA7Q34550254-5B28C2F3-5FDA-4BDF-9067-696D89AF239EQ34707472-DD78186E-1226-4798-B647-A9E450B76195Q34744036-3748E3E6-C937-4F78-A7EA-B6DB60D2BE09Q35129876-0760FBDB-8D10-4531-BD42-7A3171FD87E2Q35178629-A130A30A-9A50-4BBA-8FB1-9077223F702AQ35323907-26F53962-B89B-4C66-83EF-0C746C43B580Q35390373-C1161DFE-AAAC-4F4A-9B1E-EB9D09B6E4C1Q35544274-CDF5087F-27DE-41D2-AC58-66596C818B47Q35862776-97BCD1C6-CDC2-4A4F-9A89-DAED9000D9C3Q35928639-6556972F-7E0B-49C2-9D50-57DE0501BB3EQ36025373-0ED71D82-5F0C-4DCD-8822-CB502CBA180AQ36106776-1692E4D7-BD81-4FD4-A80F-27CEE00CCE51Q36184895-4CC5435C-C1F2-4DE1-9E78-28F3CE019F02Q36263646-5DF5A7A3-B603-4019-AC00-C4C90BBC3A58Q36272473-71EED10A-0AC7-47FD-A81B-BD21F898CA5DQ36307088-82F3FDFF-B9A5-4DC7-8499-C9988CC1194BQ36325431-2766079F-995E-4AF9-BD0D-761C3617620EQ36584260-02127129-32F5-4423-9E23-A75D4DA40F16Q36661501-88B49450-B0A0-415C-8618-FE0E04615711Q36718549-2163126D-FB09-466C-948C-04B70E24B9D2Q37074574-1B7275F8-0C6E-45BC-9C57-22923F1E0D8EQ37156552-732ED5A7-6268-46E3-8DB9-7FCCC7F8F3AFQ37193661-0BFC75CC-3402-4DFA-AA25-526193B707FD
P2860
Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents.
@ast
Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents.
@en
type
label
Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents.
@ast
Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents.
@en
altLabel
Depression in Schizophrenia: Perspective in the Era of “Atypical” Antipsychotic Agents
@en
prefLabel
Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents.
@ast
Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents.
@en
P1476
Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents.
@en
P2093
P304
P356
10.1176/APPI.AJP.157.9.1379
P407
P577
2000-09-01T00:00:00Z